SCIENTIFIC & MEDICAL RESEARCH FUNDING WORKING GROUP
(GRANTS REVIEW WORKING GROUP)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: August 3 – 4, 2005

Location:

PUBLIC SESSION: ATHENS ROOM NORTH

August 3rd: 8:00 AM to 11:00 AM

1. Call to Order and Roll Call
   1. Welcome and Introductions : Zach Hall, President of CIRM
   2. Opening Remarks: Stuart Orkin, Working Group Chair; Joan Samuelson, Working Group Vice-Chair

   [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

2. Consideration of the Charge of the Grants Review Working Group (GRWG)
3. Consideration of the By-laws for the GRWG
4. Consideration of the process for conducting review of grant applications
5. Consideration of the interim criteria for review of the scientific merit of Training Grants applications received in response to RFA 05-01
6. Consideration of the interim criteria for review of research grant applications.

CLOSED SESSION: VIENNA ROOM

August 3rd: 11:00 AM to 6:30 PM
August 4th: 8:00 AM to 6:00 PM

7. Review of Training Grant Applications Submitted in response to RFA 05-01

   Meetings of the Grant Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.